|
TRAPPC6B expression based on
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.62450000030479E-07 |
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.523090E-03 |
| Normal-vs-Stage2 |
4.235700E-03 |
| Normal-vs-Stage3 |
N/A |
| Normal-vs-Stage4 |
2.151600E-02 |
| Stage1-vs-Stage2 |
7.894000E-01 |
| Stage1-vs-Stage3 |
N/A |
| Stage1-vs-Stage4 |
2.671600E-01 |
| Stage2-vs-Stage3 |
N/A |
| Stage2-vs-Stage4 |
3.914200E-01 |
| Stage3-vs-Stage4 |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.84816999999615E-05 |
| Normal-vs-AfricanAmerican |
4.257200E-01 |
| Normal-vs-Asian |
2.802700E-04 |
| Caucasian-vs-AfricanAmerican |
1.679380E-01 |
| Caucasian-vs-Asian |
4.542200E-01 |
| AfricanAmerican-vs-Asian |
6.550200E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.398400E-03 |
| Normal-vs-Female |
1.354210E-04 |
| Male-vs-Female |
7.301800E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient BMI information is not available for 1 sample.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.437600E-02 |
| Normal-vs-Extreme_Weight |
3.593700E-04 |
| Normal-vs-Obese |
9.918000E-03 |
| Normal-vs-Extreme_Obese |
N/A |
| Normal_Weight-vs-Extreme_Weight |
4.078200E-01 |
| Normal_Weight-vs-Obese |
2.439000E-01 |
| Normal_Weight-vs-Extreme_Obese |
N/A |
| Extreme_Weight-vs-Obese |
4.839800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
N/A |
| Obese-vs-Extreme_Obese |
N/A |
|
|
CHOL : Cholangiocarcinoma
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
N/A |
| Normal-vs-Grade 2 |
6.893800E-01 |
| Normal-vs-Grade 3 |
8.045600E-01 |
| Normal-vs-Grade 4 |
1.000000E+00 |
| Grade 1-vs-Grade 2 |
N/A |
| Grade 1-vs-Grade 3 |
N/A |
| Grade 1-vs-Grade 4 |
N/A |
| Grade 2-vs-Grade 3 |
7.130400E-01 |
| Grade 2-vs-Grade 4 |
6.893800E-01 |
| Grade 3-vs-Grade 4 |
8.045600E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 5 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.809050E-04 |
| Normal-vs-N1 |
1.272500E-02 |
| N0-vs-N1 |
6.358500E-02 |
|
|
